Has xarelto gone generic?

See the DrugPatentWatch profile for xarelto

Xarelto, also known as rivaroxaban, has not yet gone generic in the United States [1]. The drug is still under patent protection, and its exclusivity period has not expired [1].

When Will Xarelto Go Generic?

The patent for Xarelto is set to expire in 2028 [1]. This means that generic versions of rivaroxaban are not expected to become available in the U.S. until that time [1].

What Are the Current Patents on Xarelto?

DrugPatentWatch.com tracks patents for Xarelto and provides detailed information on their expiration dates [1]. The current patents on Xarelto are designed to protect the drug from generic competition until their expiry in 2028 [1].

What Happens After Xarelto's Patents Expire?

Once Xarelto's patents expire, generic manufacturers will be able to produce and market their own versions of rivaroxaban [1]. This is expected to lead to increased competition and potentially lower prices for patients [1].

Who Manufactures Xarelto?

Xarelto is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson [2].

---
Sources:

[1] DrugPatentWatch.com. (n.d.). Rivaroxaban Patent Expirations. Retrieved from https://drugpatentwatch.com/
[2] Janssen Pharmaceuticals. (n.d.). Xarelto® (rivaroxaban) tablets. Retrieved from https://www.janssen.com/